NCT02954874 2026-03-17
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
8 trialsNCT02515110 2026-03-13
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
Virginia Commonwealth University
Phase NA Active not recruiting
NCT04906200 2026-02-19
YES
Ohio State University Comprehensive Cancer Center
Phase NA Active not recruiting
NCT03766009 2026-02-11
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
Alliance for Clinical Trials in Oncology
Phase NA Active not recruiting
NCT03495011 2026-02-02
MRI Characterization of Mammographically Detected DCIS
University of Washington
Active not recruiting
NCT04871516 2026-01-22
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
Rutgers, The State University of New Jersey
Phase NA Active not recruiting
NCT04754412 2026-01-20
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06234488 2026-01-12
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Medical College of Wisconsin
Active not recruiting